Skip to main content

CORRECTION article

Front. Cell. Infect. Microbiol.

Sec. Clinical Microbiology

Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1585728

This article is part of the Research Topic Perspectives in Clinical Microbiology for Combating Multi-drug Resistant Bacterial Infections: 2024/2025 View all 6 articles

Corrigendum: Exploring the clinical outcomes and molecular characteristics of Acinetobacter baumannii bloodstream infections: a study of sequence types, capsular types, and drug resistance in China

Provisionally accepted
Jiao Chen Jiao Chen 1*Yanting Shao Yanting Shao 1Zhibin Cheng Zhibin Cheng 1Guanghui Li Guanghui Li 2Fen Wan Fen Wan 1Chenyan Gao Chenyan Gao 1Danqin Wu Danqin Wu 3Dandan Wei Dandan Wei 4Yang Liu Yang Liu 4Rong Li Rong Li 5
  • 1 Nanchang Medical College, Nanchang, China
  • 2 School of Information Engineering, East China Jiaotong University, Nanchang, China
  • 3 Neurology Intensive Care Unit (ICU), First Affiliated Hospital of Nanchang University, Nanchang, China
  • 4 Department of Clinical Microbiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China
  • 5 Department of Clinical Laboratory ,Jiangxi Provincial People's Hospital, Nanchang, China

The final, formatted version of the article will be published soon.

    Results: The 30-day mortality rate of 67 patients with BSIs was 55.22%. Patients in the death group had significantly lower platelet counts and higher CRP levels than those in the survival group. Additionally, higher rates of antibiotic use (≥2 classes) and greater carbapenem exposure were observed. Among the isolates, CRAb accounted for 80.6%, ST2 accounted for 76.12%, and KL2/3/7/77/160 accounted for 65.67%. The predominant KL type was KL3, found in 19.4% of the isolates. All ST2 and KL2/3/7/77/160 isolates were CRAb. Among the isolates, 90.7% of the CRAb isolates coharbored blaOXA-23 and blaOXA-66, while one coharbored blaNDM-1 and blaOXA-23. Compared with non-ST2 and non KL2/3/7/ 77/160 infections, ST2 and KL2/3/7/77/160 infections had higher mortality rates (66.0% vs. 23.5%, P=0.002; 65.90% vs. 34.78%, P=0.015). Patients with ST2 and KL2/3/7/77/160 infections underwent more invasive procedures, received two or more antibiotics and carbapenem therapy before isolation, and had lower serum albumin levels. These isolates exhibited significantly higher resistance to antimicrobial agents. No significant differences in virulence phenotypes were observed between the two groups, except for biofilm formation between the ST2 and non-ST2 groups (P=0.002). However, these isolates harbored more virulence genes related to iron uptake and biofilm formation."The corrected sentence appears below:"Results: The 30-day mortality rate of 67 patients with BSIs was 55.22%. Patients in the death group had significantly lower platelet counts and higher CRP levels than those in the survival group. Additionally, higher rates of antibiotic use (≥2 classes) and greater carbapenem exposure were observed. Among the isolates, CRAb accounted for 80.6%, ST2 accounted for 76.12%, and KL2/3/7/77/160 accounted for 65.67%. The predominant KL type was KL3, found in 19.4% of the isolates. All ST2 and KL2/3/7/77/160 isolates were CRAb. Among the isolates, 90.7% of the CRAb isolates coharbored blaOXA-23 and blaOXA-66, while one coharbored blaNDM-1 and blaOXA-23. Compared with non-ST2 and non KL2/3/7/ 77/160 infections, ST2 and KL2/3/7/77/160 infections had higher mortality rates (66.0% vs. 23.5%, P=0.002; 65.90% vs. 34.78%, P=0.015). Patients with ST2 and KL2/3/7/77/160 infections underwent more invasive procedures, received two or more antibiotics and carbapenem therapy before isolation, and had lower serum albumin levels. These isolates exhibited significantly higher resistance to antimicrobial agents. No significant differences in virulence phenotypes were observed between the two groups, except for biofilm formation between the ST2 and non-ST2 groups (P=0.035). However, these isolates harbored more virulence genes related to iron uptake and biofilm formation.

    Keywords: Acinetobacter baumannii, Bloodstream infection, Carbapenem-resistant Acinetobacter baumannii, sequence type, capsular type

    Received: 01 Mar 2025; Accepted: 11 Mar 2025.

    Copyright: © 2025 Chen, Shao, Cheng, Li, Wan, Gao, Wu, Wei, Liu and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Jiao Chen, Nanchang Medical College, Nanchang, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more